Assembly Biosciences Ownership | Who Owns Assembly Biosciences?
Assembly Biosciences Ownership Summary
Assembly Biosciences is owned by 41.13% institutional investors, 38.52% insiders, and 20.36% retail investors. Patient square capital lp is the largest institutional shareholder, holding 1.77% of ASMB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.01% of its assets in Assembly Biosciences shares.
ASMB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Assembly Biosciences | 41.13% | 38.52% | 20.36% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.16% | 11.11% | -218.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Patient square capital lp | 135.18K | 1.77% | $3.46M |
| Blackrock funding, inc. /de | 89.67K | 1.17% | $1.62M |
| Palumbo wealth management | 34.80K | 0.45% | $890.83K |
| Ellsworth advisors | 29.95K | 0.39% | $851.78K |
| Federated hermes | 25.39K | 0.33% | $650.09K |
| Acadian asset management | 20.42K | 0.27% | $369.00K |
| Raymond james financial | 250.00 | 0.00% | $4.53K |
| Rhumbline advisers | 190.00 | 0.00% | $4.86K |
| Sbi securities | 68.00 | 0.00% | $1.74K |
| Eversource wealth advisors | 55.00 | 0.00% | $1.41K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Patient square capital lp | 135.18K | 0.93% | $3.46M |
| Palumbo wealth management | 34.80K | 0.28% | $890.83K |
| Ellsworth advisors | 29.95K | 0.18% | $851.78K |
| Federated hermes | 25.39K | 0.00% | $650.09K |
| Acadian asset management | 20.42K | 0.00% | $369.00K |
| Eversource wealth advisors | 55.00 | 0.00% | $1.41K |
| American century companies | - | - | - |
| Blackrock funding, inc. /de | 89.67K | - | $1.62M |
| Raymond james financial | 250.00 | - | $4.53K |
| Frazier financial advisors | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Patient square capital lp | 135.18K | 0.93% | 135.18K |
| Ellsworth advisors | 29.95K | 0.18% | 29.95K |
| Palumbo wealth management | 34.80K | 0.28% | 16.13K |
| Blackrock funding, inc. /de | 89.67K | - | 10.68K |
| Raymond james financial | 250.00 | - | 250.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -23.86K |
| Squarepoint ops | - | - | -18.98K |
| Marshall wace, llp | - | - | -18.04K |
| American century companies | - | - | -11.80K |
| Connor, clark & lunn investment management | - | - | -10.18K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Patient square capital lp | 135.18K | 0.93% | 135.18K | $3.46M |
| Ellsworth advisors | 29.95K | 0.18% | 29.95K | $851.78K |
| Raymond james financial | 250.00 | - | 250.00 | $4.53K |
Sold Out
| Holder | Change |
|---|---|
| Frazier financial advisors | -1.00 |
| Connor, clark & lunn investment management | -10.18K |
| American century companies | -11.80K |
| Marshall wace, llp | -18.04K |
| Squarepoint ops | -18.98K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 34 | -5.56% | 3,148,666 | -0.85% | 41 | 2.30% | 13 | -18.75% | 8 | -20.00% |
| Mar 31, 2025 | 36 | 2.86% | 3,175,639 | -0.32% | 42 | 1.81% | 16 | -23.81% | 10 | 42.86% |
| Dec 31, 2024 | 35 | 16.67% | 3,185,761 | 210.20% | 48 | 18.52% | 21 | 61.54% | 7 | - |
| Sep 30, 2024 | 30 | 7.14% | 1,026,987 | -12.62% | 16 | 3.73% | 13 | -13.33% | 7 | 40.00% |
| Jun 30, 2024 | 28 | 16.67% | 1,175,256 | 81.57% | 20 | 14.95% | 15 | 1400.00% | 5 | -78.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 127.52K | 2.01% | -2.79K |
| Vanguard US Total Market Shares ETF | 114.78K | 1.53% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 68.61K | 1.08% | -32.59K |
| Franklin Biotechnology Discv A(acc)USD | 166.20K | 1.07% | 166.20K |
| Federated Hermes MDT Small Cap Growth IS | 25.39K | 0.33% | - |
| Federated Hermes MDT SCG Institutional | 25.39K | 0.33% | - |
| Vanguard Strategic Small-Cap Equity Inv | 17.72K | 0.23% | - |
| Bridgeway Ultra-Small Company Market | 13.75K | 0.22% | - |
| Fidelity Extended Market Index | 27.00K | 0.17% | 4.20K |
| Extended Equity Market Fund K | 13.08K | 0.17% | 8.11K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 08, 2025 | GILEAD SCIENCES, INC. | - | Buy | $2.30K |
| Aug 08, 2025 | GILEAD SCIENCES, INC. | - | Buy | $24.80M |
| Aug 08, 2025 | GILEAD SCIENCES, INC. | - | Buy | $24.80M |
| Mar 31, 2025 | McHutchison John G | - | Sell | $7.46K |
| Mar 31, 2025 | Bjorkquist Jeanette M | Principal Accounting Officer | Sell | $1.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 4 |
| 2024 Q4 | 6 | 3 |
| 2024 Q3 | 2 | 2 |
| 2024 Q2 | 2 | 10 |
ASMB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools